tofacitinib

3-{(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}-3-oxopropanenitrile

UJLAWZDWDVHWOW-YPMHNXCESA-N CHEBI:71200 16 Reactome links 2 studies

2 Observed studies

2 Observed diff profiles

16 Reactome pathways

Metabolite details

Identifier: UJLAWZDWDVHWOW-YPMHNXCESA-N
InChI Key: UJLAWZDWDVHWOW-YPMHNXCESA-N
IUPAC name: 3-{(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}-3-oxopropanenitrile
Preferred name: tofacitinib
INN name: tofacitinib
Synonym: Tasocitinib
ChEBI: CHEBI:71200

Reactome pathways

R-HSA-1266695 - Interleukin-7 signaling
R-HSA-1280215 - Cytokine Signaling in Immune system
R-HSA-1643685 - Disease
R-HSA-168256 - Immune System
R-HSA-449147 - Signaling by Interleukins
R-HSA-451927 - Interleukin-2 family signaling
R-HSA-5663205 - Infectious disease
R-HSA-6785807 - Interleukin-4 and Interleukin-13 signaling
R-HSA-877300 - Interferon gamma signaling
R-HSA-8985947 - Interleukin-9 signaling
R-HSA-9020558 - Interleukin-2 signaling
R-HSA-909733 - Interferon alpha/beta signaling
R-HSA-913531 - Interferon Signaling
R-HSA-9679191 - Potential therapeutics for SARS
R-HSA-9679506 - SARS-CoV Infections
R-HSA-9824446 - Viral Infection Pathways

Observed in studies

Observed in differential profiles